Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 233

The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.

Novel Biomarkers in Autoimmune Diseases: Prolactin, Ferritin, Vitamin D, and TPA Levels in Autoimmune Diseases

Open access
ORBACH, HEDI, ZANDMAN‐GODDARD, GISELE, AMITAL, HOWARD, BARAK, VIVIAN, SZEKANECZ, ZOLTAN, SZUCS, GABRIELLA, DANKO, KATALIN, NAGY, ENDRE, CSEPANY, TUNDE, CARVALHO, JOZELIO F., DORIA, ANDREA, SHOENFELD, YEHUDA·2007·Annals of the New York Academy of Sciences

Abstract

Abstract: The development of autoimmune diseases may be influenced by hormonal, immunomodulatory, and metabolic pathways. Prolactin (PRL), ferritin, vitamin D, and the tumor marker tissue polypeptide antigen (TPA) were measured in autoimmune diseases: systemic lupus erythematosus (SLE), systemic sclerosis (SSc), rheumatoid arthritis (RA), polymyositis (PM), dermatomyositis (DM), multiple sclerosis (MS), autoimmune thyroid diseases, and antiphospholipid syndrome. Hyperprolactinemia (HPRL) was detected in 24% of PM patients, in 21% of SLE patients, in 6.7% of MS patients, 6% of RA patients, and in 3% of SSc patients. Hyperferritinemia was detected in 23% of SLE patients, 15% of DM patients, 8% of MS patients, and 4% of RA patients. The patients had relatively low levels of 25 OH Vitamin D: the average results (mean ± SD) were between 9.3 ± 4.4 to 13.7 ± 7.1 ng/mL in the different diseases, while the 25 OH Vitamin D concentrations less than 20 ng/mL are regarded as deficient. TPA levels were in the same range of the controls, elevated only in SLE. HPRL, hyperferritinemia, hypovitaminosis D, and TPA levels did not correlate with SLE activity elevated levels of rheumatoid factor or anti‐CCP antibodies in RA. HPRL, hyperferritinemia, and hypovitaminosis D have different immunological implications in the pathogenesis of the autoimmune diseases. Preventive treatment with vitamin D or therapy for HPRL with dopamine agonists, may be considered in certain cases. Hyperferritinemia may be used as an acute‐phase reactant marker in autoimmune diseases mainly SLE. TPA may be used to indicate the tendency for malignancies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1196/annals.1398.044

Cites

2 of 2 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 2 references

Cited by

See all 233

Metadata

Authors
ORBACH, H., ZANDMAN‐GODDARD, G., AMITAL, H., BARAK, V., SZEKANECZ, Z., SZUCS, G., DANKO, K., NAGY, E., CSEPANY, T., CARVALHO, J. F., DORIA, A., & SHOENFELD, Y.
Venue
Annals of the New York Academy of Sciences
Publisher
Wiley
Published
2007-08
Volume
1109
Issue
1
Pages
385-400
ISSN
  • 0077-8923 (ISSN-L)
  • 1749-6632
OpenAlex
W1533308479
Cited by
233
References
2
FWCI
6.83
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Novel Biomarkers in Autoimmune Diseases: Prolactin, Ferritin, Vitamin D, and TPA Levels in Autoimmune Diseases. https://app.cochat.ai/papers/10.1196/annals.1398.044
The paper
ORBACH, H., ZANDMAN‐GODDARD, G., AMITAL, H., BARAK, V., SZEKANECZ, Z., SZUCS, G., DANKO, K., NAGY, E., CSEPANY, T., CARVALHO, J. F., DORIA, A., & SHOENFELD, Y. (2007). Novel Biomarkers in Autoimmune Diseases: Prolactin, Ferritin, Vitamin D, and TPA Levels in Autoimmune Diseases. Annals of the New York Academy of Sciences. https://doi.org/10.1196/annals.1398.044

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.